Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide vs Standard Care for Weber B Ankle Fractures
NCT02955056Phase 4Unknown
- Sponsor
- Nottingham University Hospitals
- Start
- Oct 2016
- Primary completion
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of teriparatide in ankle fracture (2 arms), sponsored by Nottingham University Hospitals. Primary endpoint: Assessment of healing parameters of the fracture at 13 weeks. Status: unknown.
02
Drugs
teriparatide
03
Conditions
ankle fracture
Beyond the preview
Go deeper on NCT02955056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955056.